Complement Therapeutics
Clinical trials sponsored by Complement Therapeutics, explained in plain language.
-
New injection aims to slow vision loss from dry AMD
Disease control Recruiting nowThis study tests a single injection of CTx001 into the eye for people with geographic atrophy, an advanced form of dry age-related macular degeneration that causes blind spots. The goal is to see if it is safe and can slow vision loss. About 75 participants will be followed for u…
Phase: PHASE1, PHASE2 • Sponsor: Complement Therapeutics • Aim: Disease control
Last updated May 26, 2026 08:56 UTC
-
New study tracks eye disease progression to uncover clues for future treatments
Knowledge-focused Recruiting nowThis study observes 75 adults aged 55 and older with geographic atrophy (a late stage of age-related macular degeneration) to measure how the condition progresses over a short period. Researchers will use eye exams and imaging to track changes and explore links to genetics and li…
Sponsor: Complement Therapeutics • Aim: Knowledge-focused
Last updated May 26, 2026 09:00 UTC